Evidence map›Paper›PMID 35636733›Full record

ArticleContemporary clinical trials2022

COMbined Exercise Trial (COMET) to improve cognition in older adults: Rationale and methods.

Amanda Szabo-Reed, Jonathan Clutton, Sydney White, Angela Van Sciver, Dreu White, Jill Morris, Laura Martin, Rebecca Lepping, Ashley Shaw, Jaime Perales Puchalt and 5 more

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Amanda Szabo-ReedKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Internal Medicine, Division of Physical Activity and Weight Management, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: aszabo2@ku.edu.
Jonathan CluttonKU Alzheimer's Disease Research Center, Fairway, KS, USA.
Sydney WhiteKU Alzheimer's Disease Research Center, Fairway, KS, USA.
Angela Van SciverKU Alzheimer's Disease Research Center, Fairway, KS, USA.
Dreu WhiteKU Alzheimer's Disease Research Center, Fairway, KS, USA.
Jill MorrisKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Laura MartinDepartment of Population Health, University of Kansas Medical Center, Kansas City, KS, USA; Hoglund Biomedical Imaging Center, University of Kansas Medical Center, Kanas City, KS, USA.
Rebecca LeppingKU Alzheimer's Disease Research Center, Fairway, KS, USA; Hoglund Biomedical Imaging Center, University of Kansas Medical Center, Kanas City, KS, USA.
Ashley ShawKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Jaime Perales PuchaltKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Robert MontgomeryDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Jonathan MahnkenDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Richard WashburnDepartment of Internal Medicine, Division of Physical Activity and Weight Management, University of Kansas Medical Center, Kansas City, KS, USA.
Jeffrey BurnsKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Eric D VidoniKU Alzheimer's Disease Research Center, Fairway, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
University of Kansas Medical Center · USAlzheimer’s Disease Neuroimaging Initiative · USImaging Center · US

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jaime Perales Puchalt · 2021 to 2026
$25.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BROOKS, WILLIAM M. · 2011 to 2020
$16.6M
Differential Effects of Exercise Modality on Cognition and Brain in Older AdultsR01AG070036 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SZABO-REED, AMANDA N., VIDONI, ERIC DENNIS · 2021 to 2025
$6.9M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
NIA NIH HHS L60 AG069211NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG070036NIA NIH HHS T32 AG078114
6 · The paper itself

Abstract

Substantial evidence suggests physical exercise may sustain cognitive function and perhaps prevent Alzheimer's Disease (1, 2). Current public health recommendations call for older adults to do at least 150 min a week of aerobic exercise (e.g. walking) and twice a week resistance exercise (e.g. weight lifting) for physical health. Yet, much remains unknown about how these exercise modalities support brain health independently or in combination. The COMbined Exercise Trial (COMET) is designed to test the combined and independent effects of aerobic and resistance training specifically focusing on exercise-related changes in 1) cognitive performance, 2) regional brain volume, 3) physical function, and 4) blood-based factors. To explore these questions, we will enroll 280 cognitively normal older adults, age 65-80 years, into a 52-week community-based exercise program. Participants will be randomized into one of four arms: 1) flexibility/toning- control 2) 150 min of aerobic exercise only, 3) progressive resistance training only, or 4) combined aerobic and progressive resistance training. Outcomes assessed include a comprehensive cognitive battery, blood biomarkers, brain magnetic resonance imaging, physiological biomarkers, cardiorespiratory fitness, physical function, and battery of psychosocial questionnaires is assessed at baseline, 6 and 12-months. COMET will provide rigorous randomized controlled trial data to understand the effects of the most common exercise modalities, and their combination (i.e., the standard public health recommendation), on brain health.

Indexed as

CognitionExercise TherapyAgedAged, 80 and overBiomarkersExerciseHumansRandomized Controlled Trials as TopicTreatment OutcomeBiomarkersAerobic activityAlzheimer's diseaseBrain structureCognitionExerciseFitnessResistance training

Identifiers

PMID35636733
PMCPMC9354507
OpenAlexW4281661144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.